Italy: Industrial Digitization Marchesini Signs 125 Million Dollar Transaction with Sea Vision

Editor: Alexander Stark

The Marchesini Group has acquired a stake of 48 % in Sea Vision, a producer of vision and inspection systems used in drug quality and counterfeiting control.

Related Vendors

"The best way to define industry 4.0 is 'digitalized manufacturing'," said Maurizio Marchesini.
"The best way to define industry 4.0 is 'digitalized manufacturing'," said Maurizio Marchesini.
(Bild: Marchesini Group)

Pianoro/Italy — Sea Vision is a rapidly growing group employing over a hundred people and a turnover of $ 40 million in 2017. Following drug serialization regulations in the EU, USA and China, the company expects a turnover increase of 40 % in 2018, thanks to the fact that drug serialization is mandatory in the EU, USA and China and now also in Brazil, Russia and North Africa.

The manufacturer of vision and inspection systems will remain technically and commercially independent and will continue to be managed by its founders Luigi Carrioli and Michele Cei, assisted by the Sales Director Marco Baietti and the CFO Matteo Boiardi, backed in the Board of Directors by Maurizio Marchesini (President of the Marchesini Group), Pietro Cassani (CEO) and Pietro Tomasi (Sales Director).

According to Pietro Cassani, this agreement will allow the packaging machine manufacturer to create machines that are unified with Sea Vision’s systems. The aim of this acquisition was to become the key reference on Industry 4.0 topics for pharmaceutical enterprises.

At the Headquarters in Pianoro, the Marchesini Group is about to inaugurate a new factory built entirely for 3D printing, which it considers one of the main “declinations” of the Industry 4.0 model. The building will host all the three-dimensional printers currently used by the Group, together with new models that will work 24 hours a day to prototype samples in short times and to develop machine parts that up to now have been produced externally. The department will become the heart of the Group's Industry 4.0 efforts, making it possible to curb costs and to monitor production planning, machine wear and tear and error management.

Construction will soon also commence on the new cosmetic division, which will support the pharmaceutical department. Another of the Group’s factories in Pianoro is being renovated and will allow the Group to consolidate its business related to “second life” machinery.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent